Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
wasabi.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020
Creator
Zheng, Yi
Liu, Liang
Tang, Yijun
State,
El-Han, Leung
Leung, Lai-Han
Liu, Yuquan
Qian, Xin
Tang, Qian
Wang, Meifang
Xiong, Chang
Xiong, Zheng
Source
Elsevier; Medline; PMC
abstract
AIM: Since December 2019, new COVID-19 outbreaks have occurred and spread around the world. However, the clinical characteristics of patients in other areas around Wuhan, Hubei Province are still unclear. In this study, we performed epidemiological and clinical characteristics analysis on these regional cases. METHODS: We retrospectively investigated COVID-19 patients positively confirmed by nucleic acid Q-PCR at Taihe Hospital from January 16 to February 4, 2020. Their epidemiological, clinical manifestations, and imaging characteristics were analysed. RESULTS: Among the 73 patients studied, 12.3 % developed symptoms after returning to Shiyan from Wuhan, and 71.2 % had a history of close contact with Wuhan personnel or confirmed cases. Among these patients, 9 cases were associated with family clustering. The first main symptoms presented by these patients were fever (84.9 %) and cough (21.9 %). The longest incubation period was 26 days, and the median interval from the first symptoms to admission was 5 days. Of the patients, 67.1 % were originally healthy people with no underlying diseases, others mostly had common comorbidities including hypertension (12.3 %) and diabetes (5.5 %), 10.9 % were current smokers, 30.1 % had low white blood cell counts and 45.2 % showed decreased lymphocytes at the first time of diagnosis. CT scans showed that multiple patchy ground glass shadows outside of the patient lungs were commonly observed, and a single sub-pleural sheet of ground glass shadow with enhanced vascular bundles was also found located under the pleura. Patient follow-up to February 14 presented 38.4 % severe cases and 2.7 % critical cases. After follow-up, the parameter of lymphocyte counts below 0.8 × 10(9)/L cannot be used to predict severe and critical groups from the ordinary group, and a lower proportion of smokers and higher proportion of diabetes patients occur in the poor outcome group. Other co-morbidities are observed but did not lead to poor outcomes. CONCLUSION: The epidemiological characteristics of patients in the area around Wuhan, such as Shiyan, at first diagnosis are described as follows: Patients had histories of Wuhan residences in the early stage and family clustering in the later period. The incubation period was relatively long, and the incidence was relatively hidden, but the virulence was relatively low. The initial diagnosis of the patients was mostly ordinary, and the percentage of critical patients who evolved into the ICU during follow-up is 2.7 %, which is lower than the 26.1 % reported by Wuhan city. According to the Shiyan experience, early diagnosis with multiple swaps of the Q-PCR test and timely treatment can reduce the death rate. Diabetes could be one of the risk factors for progression to severe/critical outcomes. No evidence exists that smoking protects COVID-19 patients from developing to severe/critical cases, and the absolute number of lymphocytes at initial diagnosis could not predict the progression risk from severe to critical condition. Multivariate regression analysis should be used to further guide the allocation of clinical resources.
has issue date
2020-04-30
(
xsd:dateTime
)
bibo:doi
10.1016/j.phrs.2020.104821
bibo:pmid
32360481
has license
no-cc
sha1sum (hex)
27964e8b3f8b3088b382c0cc647a2ddb6228b20c
schema:url
https://doi.org/10.1016/j.phrs.2020.104821
resource representing a document's title
Epidemiological and clinical characteristics analysis of COVID-19 in the surrounding areas of Wuhan, Hubei Province in 2020
has PubMed Central identifier
PMC7191275
has PubMed identifier
32360481
schema:publication
Pharmacol Res
resource representing a document's body
covid:27964e8b3f8b3088b382c0cc647a2ddb6228b20c#body_text
is
schema:about
of
named entity 'initial'
named entity 'patients'
named entity 'January 16'
named entity 'COVID-19'
named entity 'fever'
named entity 'December'
named entity 'time'
named entity 'Results'
named entity 'family'
named entity 'cases'
named entity 'presented'
named entity 'multiple'
named entity 'symptoms'
named entity 'Aim'
named entity 'ground glass'
named entity 'COVID-19'
named entity 'LONG'
named entity 'EPIDEMIOLOGICAL'
named entity 'AIM'
named entity 'UP TO'
named entity 'DIABETES'
named entity 'PATCHY'
named entity 'CHARACTERISTICS'
named entity 'CRITICAL'
named entity 'ACCORDING'
named entity 'PEOPLE'
named entity 'DEVELOPING'
named entity 'ALLOCATION'
named entity 'INITIAL DIAGNOSIS'
named entity 'PRESENTED'
named entity 'GROUPS'
named entity 'AREAS'
named entity 'THESE'
named entity 'SHADOWS'
named entity 'LYMPHOCYTES'
named entity 'VIRULENCE'
named entity '12.3'
named entity 'NEW'
named entity 'BUT'
named entity 'patients'
named entity 'close'
named entity 'incubation period'
named entity 'analysed'
named entity 'shadow'
named entity 'Methods'
named entity 'commonly'
named entity 'Since'
named entity 'diabetes'
named entity 'symptoms'
named entity 'patchy'
named entity 'ICU'
named entity 'cases'
named entity 'areas'
named entity 'diseases'
named entity 'According'
named entity 'white blood cell'
named entity 'diagnosis'
named entity 'risk'
named entity 'initial'
named entity '2019'
named entity 'study'
named entity 'COVID-19'
named entity 'diagnosis'
named entity 'imaging'
named entity 'patients'
named entity 'hypertension'
named entity 'epidemiological'
named entity 'originally'
named entity 'area'
named entity 'progression'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 8
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software